Skip to main content
. Author manuscript; available in PMC: 2022 Feb 7.
Published in final edited form as: Gynecol Oncol. 2020 Oct 31;160(1):302–311. doi: 10.1016/j.ygyno.2020.10.010

Fig. 5.

Fig. 5.

Mebendazole, PRIMA-1MET drug combination induces apoptosis in in vitro. (A) Western blots of cleaved caspase 9, Cleaved Caspase 3 and cleaved PARP protein expression level after treatment with mebendazole and PRIMA-1MET in ovarian cancer cells with different p53 status. Histogram of cleaved (B) caspase 9 and (C) caspase 3 protein level were normalized to the β actin levels. (D) Cleaved PARP to PARP ratio level. Statistical analysis was performed using one-way ANOVA followed by Tukeys’ post hoc test. * p < 0.05, ** p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001.